Women who got the enzyme injection felt less self-conscious, embarrassed, or like they looked older because of their cellulite — and they were much happier with how their skin looked.
Scientific Claim
CCH-aaes treatment significantly improves patient-reported emotional and aesthetic impact of moderate-to-severe buttock cellulite, with 61.6% of treated women reporting at least a one-level improvement in global aesthetic appearance and a mean reduction of 5.4 points in cellulite-related emotional distress compared to placebo.
Original Statement
“A significantly larger percentage of women treated with CCH-aaes had a ≥1-level improvement in S-GAIS versus those treated with placebo (61.6% versus 30.5%; P ≤ 0.001)... Women treated with CCH-aaes had a significantly greater mean improvement from baseline in PR-CIS total score at Day 71 compared with placebo-treated women (-11.7 versus -6.2; Δ-5.4 [95% CI, -7.0 to -3.9]; P < 0.001).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
Patient-reported outcomes were measured using validated scales in a randomized, placebo-controlled trial, allowing causal inference. The language 'significantly improves' is appropriate for this high-quality evidence.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aIn EvidenceConsistent improvement in patient-reported outcomes across multiple RCTs for CCH-aaes in cellulite.
Consistent improvement in patient-reported outcomes across multiple RCTs for CCH-aaes in cellulite.
What This Would Prove
Consistent improvement in patient-reported outcomes across multiple RCTs for CCH-aaes in cellulite.
Ideal Study Design
A systematic review and meta-analysis of all RCTs using S-GAIS, PR-CIS, SSCTA, and SSRS in adult women with moderate-to-severe buttock cellulite treated with CCH-aaes (0.84 mg ×3) vs placebo, measuring mean change in scores at 71 days.
Limitation: Cannot assess long-term durability of emotional benefits beyond 3 months.
Randomized Controlled TrialLevel 1bIn EvidenceCausal effect of CCH-aaes on patient-reported emotional and aesthetic outcomes.
Causal effect of CCH-aaes on patient-reported emotional and aesthetic outcomes.
What This Would Prove
Causal effect of CCH-aaes on patient-reported emotional and aesthetic outcomes.
Ideal Study Design
A double-blind RCT of 300 adult women with moderate-to-severe buttock cellulite randomized to CCH-aaes (0.84 mg ×3) or placebo, with primary endpoints being change in PR-CIS total score and S-GAIS response at Day 71.
Limitation: Limited to short-term psychological impact; does not assess long-term satisfaction.
Prospective Cohort StudyLevel 2bReal-world persistence of improved self-perception and satisfaction after CCH-aaes.
Real-world persistence of improved self-perception and satisfaction after CCH-aaes.
What This Would Prove
Real-world persistence of improved self-perception and satisfaction after CCH-aaes.
Ideal Study Design
A prospective cohort study of 400 women treated with CCH-aaes for buttock cellulite, measuring PR-CIS, SSCTA, and SSRS at 3, 6, and 12 months post-treatment to assess durability of emotional benefits.
Limitation: No control group; confounding by concurrent treatments or life events.
Cross-Sectional SurveyLevel 4Association between CCH-aaes treatment and current patient satisfaction in a real-world population.
Association between CCH-aaes treatment and current patient satisfaction in a real-world population.
What This Would Prove
Association between CCH-aaes treatment and current patient satisfaction in a real-world population.
Ideal Study Design
A nationwide survey of 1000 women who received CCH-aaes for buttock cellulite, asking about satisfaction (SSCTA), emotional impact (PR-CIS), and willingness to repeat treatment, stratified by time since treatment.
Limitation: Cannot establish causation or temporal sequence; subject to recall bias.
In Vitro StudyLevel 5Biological plausibility of collagenase-induced tissue remodeling affecting skin aesthetics.
Biological plausibility of collagenase-induced tissue remodeling affecting skin aesthetics.
What This Would Prove
Biological plausibility of collagenase-induced tissue remodeling affecting skin aesthetics.
Ideal Study Design
An in vitro model using human dermal fibroblasts and adipocytes in a 3D collagen matrix, treated with CCH-aaes, measuring changes in matrix stiffness, adipocyte size, and fibroblast activity over 7 days.
Limitation: Cannot replicate complex in vivo tissue interactions or patient perception.
Evidence from Studies
Supporting (0)
Contradicting (1)
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
The study shows the treatment helps smooth cellulite for some women, but it doesn’t show the exact numbers the claim says — like 61.6% improvement or big drops in emotional distress — so the claim is too specific and not backed up.